New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Trial ID or NCT#
Status
Purpose
The purpose of this trial is to determine whether treatment with valsartan will have beneficial effect in early hypertrophic cardiomyopathy (HCM) by assessing many domains that reflect myocardial structure, function and biochemistry.
Official Title
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Eligibility Criteria
Investigator(s)
Contact us to find out if this trial is right for you.
CONTACT
Euan Ashley, MD, PhD
(650) 498-4900
View on ClinicalTrials.gov
About this Clinical Trial
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Your Message Will Go To
Euan Ashley, MD, PhD650-498-4900